Risk and Mitigation of Coronary Obstruction in Transcatheter Aortic Valve Replacement

Giorgio A Medranda1, Toby Rogers2

  • 1Section of Interventional Cardiology, MedStar Washington Hospital Center, 110 Irving Street NW, Suite 4B1, Washington, DC 20010, USA.

Insights

Acute coronary artery occlusion after transcatheter aortic valve replacement is a rare complication. Risk factors include aortic root and valve types, with prevention via leaflet laceration, but bailout stenting or surgery carry high risks.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiac Surgery

Background:

  • Acute coronary artery occlusion is a rare but serious complication following transcatheter aortic valve replacement (TAVR).
  • Coronary obstruction is defined by angiographic evidence of new partial or complete blockage of a coronary artery.
  • Patient risk is influenced by aortic root anatomy, native aortic valve type, and the specific transcatheter heart valve used.

Purpose of the Study:

  • To review the risk factors, prevention strategies, and management of acute coronary artery obstruction after TAVR.
  • To highlight the challenges and outcomes associated with interventions for this complication.

Main Methods:

  • Review of existing literature and case reports on coronary obstruction post-TAVR.
  • Analysis of patient-specific anatomical and procedural factors contributing to risk.
  • Evaluation of preventative and interventional techniques.

Main Results:

  • Key risk factors identified: specific aortic root dimensions, valve designs (e.g., supra-annular valves), and TAVR device characteristics.
  • Intentional leaflet laceration is a technique to prevent obstruction.
  • Bailout stenting is technically challenging, and conversion to open-heart surgery is often required, associated with significant morbidity and mortality.

Conclusions:

  • Acute coronary obstruction is a critical complication of TAVR requiring careful patient selection and procedural planning.
  • Preventative measures are preferred, as interventional management carries substantial risks.
  • Further research into optimizing TAVR techniques to minimize coronary obstruction is warranted.

Related Concept Videos

Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
73
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
46
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
71
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
401
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
53
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
51